Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 56089-56090 [2022-19656]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 15, 2022 (87 FR 36147).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–19657 Filed 9–12–22; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
jspears on DSK121TN23PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—1EdTech Consortium, Inc.
Notice is hereby given that, on August
18, 2022, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), 1EdTech
Consortium, Inc. (‘‘1EdTech
Consortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Better Examinations,
Dublin, IRELAND; BPS Bildungsportal
Sachsen GmbH, Chemnitz, GERMANY;
Coins for College, Antioch, CA;
Everyone’s Island, Inc., Montgomery,
TX; IQ4, Woodcliff Lake, NJ; Madison
County Schools, Danielsville, GA;
Minnesota State Colleges and University
System, St. Paul, MN; The National
eLearning Center, Riyadh, SAUDI
ARABIA; National Society of
Leadership and Success (NSLS), Miami,
FL; New Hanover County Schools,
Wilmington, NC; Parkway School
District, Chesterfield, MO; Perris Union
High School District, Perris, CA; Pioneer
RESA, Cleveland, GA; Tigard-Tualatin
School District, Tigard, OR;
Independent School District No. 1 of
Tulsa County, Oklahoma AKA Tulsa
Public Schools, Tulsa, OK; and
Waynesboro Area School District,
Waynesboro, PA, have been added as
parties to this venture.
Also, VidGrid, Schaumburg, IL; Texas
Education Agency, Austin, TX; Early
Learning Quick Assessment (ELQA),
Moore, OK; Campus EDU, Marion, IN;
Follett School Solutions, McHenry, IL;
edX, Cambridge, MA; Illuminate
Education, Irvine, CA; and ClassGather,
La Vergne, TN, have withdrawn as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
Membership in this group research
project remains open, and 1EdTech
Consortium intends to file additional
written notifications disclosing all
changes in membership.
On April 7, 2000, 1EdTech
Consortium filed its original notification
pursuant to Section 6(a) of the Act. The
Department of Justice published a notice
in the Federal Register pursuant to
Section 6(b) of the Act on September 13,
2000 (65 FR 55283).
The last notification was filed with
the Department on June 1, 2022. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 15, 2022 (87 FR 36147).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–19661 Filed 9–12–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on July
15, 2022, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical Technology
Enterprise Consortium (‘‘MTEC’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 1Focus LLC, Clearwater,
FL; 4M Biotech, Ltd., Victoria,
CANADA; Action Medical Technologies
LLC, Conshohocken, PA; Advanced
Biomimetic Sensors, Inc., Bethesda, MD;
Aspen Stem Cell Institute LLC, Basalt,
CO; A-Tech LLC dba BlueHalo Labs,
Albuquerque, NM; Biomeme, Inc.,
Philadelphia, PA; BiotechPharma,
Corp., Severna Park, MD; Bodies Done
Right, Mayfield Village, OH; Cellphire,
Inc. dba Cellphire Therapeutics, Inc.,
Rockville, MD; Collaborative Effort, Inc.
dba RAIN Incubator, Tacoma, WA;
Cornell University, Ithaca, NY;
DeltaStrac LLC, New Windsor, MD;
Eagle Global Scientific LLC, San
Antonio, TX; Elephant Ventures LLC,
New York, NY; Gateway Biotechnology,
Inc., St. Louis, MO; HealthTech Connex,
Surrey, CAN; Hememics
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
56089
Biotechnologies, Inc., Gaithersburg, MD;
Human Systems Integration, Inc., East
Walpole, MA; IDION, Inc., Darien, CT;
Independent Platform LLC, Salem, OR;
International AIDS Vaccine Initiative,
New York, NY; Laulima Government
Solutions, Orlando, FL; Link to Learn,
Denver, CO; Mainstream Engineering
Corp., Rockledge, FL; MDB, Inc.,
Washington, DC; MedCu Technologies
Ltd., Herzliya, ISR; Nanobionic
Technologies Limited, Nicosia, CYP;
Neunos ZRt, Szeged, HUN; Neuro11
Technologies, Inc., Cambridge, MA;
NeuroStat Analytical Solutions, Great
Falls, VA; Neursantys, Inc., Chicago, IL;
OARK ApS, Hammel, DNK; Omnica
Corp., Irvine, CA; Oregon Biomedical
Engineering Institute, Inc., Wilsonville,
OR; Palantir USG, Inc., Palo Alto, CA;
PathoGene, Inc., Monrovia, CA; Pixel
and Timber LLC, Cincinnati, OH;
Polaris Sensor Technologies, Inc.,
Huntsville, AL; Powerbuilding Holdings
Corp., Staten Island, NY; Proxima
Clinical Research, Houston, TX; Puerto
Rico Science, Technology and Research
Trust, San Juan, PRI; Qidni Labs, Inc.,
Buffalo, NY; Resonantia Diagnostics,
New York, NY; Resusitech, Inc., Menlo
Park, CA; Rx Bandz, Austin, TX;
Senseye, Inc., Austin, TX; Shock
Therapeutics Biotechnologies, Inc.,
Baltimore, MD; Siemens Medical
Solutions USA, Inc., Princeton, NJ;
Singularity Scitech LLC, Bronxville, NY;
SmartHealth Catalyzer, Inc.,
Riverwoods, IL; Social Science
Innovations Corp., New York, NY;
Sonogen Medical, Inc., Chevy Chase,
MD; Sonosa Medical, Inc., Baltimore,
MD; Spectral MD, Inc., Dallas, TX;
TensionSquare LLC, Port Charlotte, FL;
Terasaki Institute for Biomedical
Innovation, Los Angeles, CA; The
Mullings Group, Delray Beach, FL;
TMG360 Media, Delray Beach, FL;
Triple Ring Technologies, Newark, CA;
TroutHouseTech LLC, Arlington, VA;
University of Alaska Fairbanks,
Fairbanks, AK; University of Notre
Dame, Notre Dame, IN; UTL, Inc.,
Carlsbad, CA; Vadum, Inc., Raleigh, NC;
Virion Therapeutics LLC, Newark, DE;
have been added as parties to this
venture.
Also, Abfero Pharmaceuticals, Inc.,
Boston, MA; Aerpio Pharmaceuticals,
Cincinnati, OH; AirSupport LLC,
Baltimore, MD; Alertgy, Inc.,
Melbourne, FL; Aptive Resources LLC,
Alexandria, VA; Arteriocyte, Inc. dba
Compass Biomedical, Hopkinton, MA;
Ashvattha Therapeutics, Inc., Redwood
City, CA; Asymmetric Technologies
LLC, Columbus, OH; Bettermeant, Inc.,
Berkeley, CA; Boa Biomedical, Inc.,
Cambridge, MA; Board of Trustees of
E:\FR\FM\13SEN1.SGM
13SEN1
jspears on DSK121TN23PROD with NOTICES
56090
Federal Register / Vol. 87, No. 176 / Tuesday, September 13, 2022 / Notices
the Leland Stanford Junior University,
Palo Alto, CA; Carnegie Mellon
University, Pittsburg, PA; Celerens LLC,
Clarksville, MD; Data Intelligence
Technologies, Inc., Arlington, VA;
DataRobot, Inc., Boston, MA; Dawson
Technical, Inc., Irvine, CA; Diagnoss,
Inc., Pomona, CA; Diomics Corp.,
Murrieta, CA; DocBox, Inc., Waltham,
MA; Embody LLC, Norfolk, VA;
Evidence Based Psychology LLC dba
Susan David, Newton, MA; FirstString
Research, Inc., Mt. Pleasant, SC; Five
Vital Signs, Houston, TX; FloTBI, Inc.,
Cleveland, OH; Friedman Research
Corp., Austin, TX; Full Spectrum
Omega, Inc., Los Angeles, CA; Fusion
Consulting, Inc., Farmers Branch, TX;
General Biologics, Inc., Cambridge, MA;
Global Institute of Stem Cell Therapy
and Research, Inc., San Diego, CA; H&H
Medical Corp., Williamsburg, VA;
Healing Our Heroes Foundation dba The
Mission After, Del Mar, CA; Hybrid
Plastics, Inc., Hattiesburg, MS; Iacta
Pharmaceuticals, Inc., Irvine, CA;
Intelligent Automation, Inc., Rockville,
MD; IRegained, Inc., Sudbury, CAN;
KMASS Solutions, El Paso, TX; Kopis
Mobile LLC, Flowood, MS; L–3 Applied
Technologies, Inc., San Diego, CA; Levi
Diagnostics, Inc., Fall River, MA;
LexisNexis Risk Solutions, Inc.,
Washington, DC; Life365 Inc.,
Scottsdale, AZ; luxML LLC, San
Antonio, TX; MadApparel Ind. dba
Athos, Redwood City, CA; ManTech
Advanced Systems International, Inc.,
Herndon, VA; Medical Center of the
Americas Foundation, El Paso, TX;
Medical Informatics Corp., Houston, TX;
MEDX SpA, Regio´n metropolitana,
Santiago de Chile, CHL; Moleculin
Biotech, Inc., Houston, TX; Movement
Rx Physical Therapy, P.C., San Diego,
CA; NanoOxygenic LLC, Dallas, TX;
NeurAegis, Inc., Southborough, MA;
Neuronasal, Inc., Wexford, PA; Nexsys
Electronics Inc. dba Medweb, San
Francisco, CA; Nostromo LLC,
Kennebunk, ME; Novel Technologies
Holdings Limited, Manchester, NH;
Noveome Biotherapeutics, Inc.,
Pittsburg, PA; Obatala Sciences, Inc.,
New Orleans, LA; Odin Technologies,
Charlotte, NC; OLGS, Inc., Imperial, PA;
Oregon Health & Science University,
Portland, OR; Osteal Therapeutics, Inc.,
San Clemente, CA; Overseas Strategic
Consulting, Ltd, Philadelphia, PA;
Oxygenium, Inc., Great Neck, NY;
Panakeia LLC, Newport News, VA;
PercuSense, Inc., Valencia, CA; Platelet
BioGenesis, Inc., Cambridge, MA;
Presidio Government Solutions LLC,
Reston, VA; Programs Management
Analytics & Technologies, Inc., Norfolk,
VA; Q30 Sports Science LLC, Westport,
VerDate Sep<11>2014
17:30 Sep 12, 2022
Jkt 256001
CT; QuesGen Systems, Burlingame, CA;
Renaissance Biotech LLC, Malibu, CA;
Resolys Bio, Inc., Delanson, NY;
ServiceNow, Inc., Vienna, VA;
SpherIngenics, Inc., Richmond, VA;
StataDX, Inc., Cambridge, MA;
Synthesis Technologies, Inc., Pasadena,
CA; Tanner Research, Inc., Duarte, CA;
TeleCommunication Systems, Inc.,
Annapolis, MD; Through The Cords
LLC, Salt Lake City, UT; Traumatic
Direct Transfusion Devices LLC,
Raleigh, NC; Tunnell Consulting, Inc.,
Bethesda, MD; University of
Connecticut, Storrs, CT; University of
Kansas Medical Center Research
Institute, Inc., Kansas City, KS;
ViiNetwork, Inc ViiMed, Washington,
DC; Wearable Artificial Organs, Inc.,
Beverly Hills, CA; WearOptimo,
Woolloongabba, Queensland, AUS;
Western Michigan University Homer
Stryker M.D. School of Medicine,
Kalamazoo, MI; XSurgical, Inc.,
Ipswich, MA; Zansors LLC, Arlington,
VA; have withdrawn as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on April 14, 2022. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on May 13, 2022 (87 FR 29382).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–19656 Filed 9–12–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc.
Notice is hereby given that, on August
14, 2022, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), UHD Alliance, Inc.
(‘‘UHD Alliance’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, PRISM TECH PRIVATE
LIMITED, Singapore, SINGAPORE has
been added as a party to this venture.
No other changes have been made in
either the membership or the planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership. On June 17, 2015, UHD
Alliance filed its original notification
pursuant to section 6(a) of the Act. The
Department of Justice published a notice
in the Federal Register pursuant to
section 6(b) of the Act on July 17, 2015
(80 FR 42537).
The last notification was filed with
the Department on June 7, 2022. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on August 1, 2022 (87 FR 47003).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–19663 Filed 9–12–22; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to The National
Cooperative Research and Production
Act of 1993—Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of the
American Institute for Manufacturing
Integrated Photonics
Notice is hereby given that, on August
8, 2022, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), the Integrated
Photonics Institute for Manufacturing
Innovation operating under the name of
the American Institute for
Manufacturing Integrated Photonics
(‘‘AIM Photonics’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Lowell Observatory,
Flagstaff, AZ; and Physical Sciences
Inc., Andover, MA, have been added as
parties to this venture.
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56089-56090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19656]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on July 15, 2022, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, 1Focus LLC, Clearwater, FL; 4M Biotech, Ltd., Victoria,
CANADA; Action Medical Technologies LLC, Conshohocken, PA; Advanced
Biomimetic Sensors, Inc., Bethesda, MD; Aspen Stem Cell Institute LLC,
Basalt, CO; A-Tech LLC dba BlueHalo Labs, Albuquerque, NM; Biomeme,
Inc., Philadelphia, PA; BiotechPharma, Corp., Severna Park, MD; Bodies
Done Right, Mayfield Village, OH; Cellphire, Inc. dba Cellphire
Therapeutics, Inc., Rockville, MD; Collaborative Effort, Inc. dba RAIN
Incubator, Tacoma, WA; Cornell University, Ithaca, NY; DeltaStrac LLC,
New Windsor, MD; Eagle Global Scientific LLC, San Antonio, TX; Elephant
Ventures LLC, New York, NY; Gateway Biotechnology, Inc., St. Louis, MO;
HealthTech Connex, Surrey, CAN; Hememics Biotechnologies, Inc.,
Gaithersburg, MD; Human Systems Integration, Inc., East Walpole, MA;
IDION, Inc., Darien, CT; Independent Platform LLC, Salem, OR;
International AIDS Vaccine Initiative, New York, NY; Laulima Government
Solutions, Orlando, FL; Link to Learn, Denver, CO; Mainstream
Engineering Corp., Rockledge, FL; MDB, Inc., Washington, DC; MedCu
Technologies Ltd., Herzliya, ISR; Nanobionic Technologies Limited,
Nicosia, CYP; Neunos ZRt, Szeged, HUN; Neuro11 Technologies, Inc.,
Cambridge, MA; NeuroStat Analytical Solutions, Great Falls, VA;
Neursantys, Inc., Chicago, IL; OARK ApS, Hammel, DNK; Omnica Corp.,
Irvine, CA; Oregon Biomedical Engineering Institute, Inc., Wilsonville,
OR; Palantir USG, Inc., Palo Alto, CA; PathoGene, Inc., Monrovia, CA;
Pixel and Timber LLC, Cincinnati, OH; Polaris Sensor Technologies,
Inc., Huntsville, AL; Powerbuilding Holdings Corp., Staten Island, NY;
Proxima Clinical Research, Houston, TX; Puerto Rico Science, Technology
and Research Trust, San Juan, PRI; Qidni Labs, Inc., Buffalo, NY;
Resonantia Diagnostics, New York, NY; Resusitech, Inc., Menlo Park, CA;
Rx Bandz, Austin, TX; Senseye, Inc., Austin, TX; Shock Therapeutics
Biotechnologies, Inc., Baltimore, MD; Siemens Medical Solutions USA,
Inc., Princeton, NJ; Singularity Scitech LLC, Bronxville, NY;
SmartHealth Catalyzer, Inc., Riverwoods, IL; Social Science Innovations
Corp., New York, NY; Sonogen Medical, Inc., Chevy Chase, MD; Sonosa
Medical, Inc., Baltimore, MD; Spectral MD, Inc., Dallas, TX;
TensionSquare LLC, Port Charlotte, FL; Terasaki Institute for
Biomedical Innovation, Los Angeles, CA; The Mullings Group, Delray
Beach, FL; TMG360 Media, Delray Beach, FL; Triple Ring Technologies,
Newark, CA; TroutHouseTech LLC, Arlington, VA; University of Alaska
Fairbanks, Fairbanks, AK; University of Notre Dame, Notre Dame, IN;
UTL, Inc., Carlsbad, CA; Vadum, Inc., Raleigh, NC; Virion Therapeutics
LLC, Newark, DE; have been added as parties to this venture.
Also, Abfero Pharmaceuticals, Inc., Boston, MA; Aerpio
Pharmaceuticals, Cincinnati, OH; AirSupport LLC, Baltimore, MD;
Alertgy, Inc., Melbourne, FL; Aptive Resources LLC, Alexandria, VA;
Arteriocyte, Inc. dba Compass Biomedical, Hopkinton, MA; Ashvattha
Therapeutics, Inc., Redwood City, CA; Asymmetric Technologies LLC,
Columbus, OH; Bettermeant, Inc., Berkeley, CA; Boa Biomedical, Inc.,
Cambridge, MA; Board of Trustees of
[[Page 56090]]
the Leland Stanford Junior University, Palo Alto, CA; Carnegie Mellon
University, Pittsburg, PA; Celerens LLC, Clarksville, MD; Data
Intelligence Technologies, Inc., Arlington, VA; DataRobot, Inc.,
Boston, MA; Dawson Technical, Inc., Irvine, CA; Diagnoss, Inc., Pomona,
CA; Diomics Corp., Murrieta, CA; DocBox, Inc., Waltham, MA; Embody LLC,
Norfolk, VA; Evidence Based Psychology LLC dba Susan David, Newton, MA;
FirstString Research, Inc., Mt. Pleasant, SC; Five Vital Signs,
Houston, TX; FloTBI, Inc., Cleveland, OH; Friedman Research Corp.,
Austin, TX; Full Spectrum Omega, Inc., Los Angeles, CA; Fusion
Consulting, Inc., Farmers Branch, TX; General Biologics, Inc.,
Cambridge, MA; Global Institute of Stem Cell Therapy and Research,
Inc., San Diego, CA; H&H Medical Corp., Williamsburg, VA; Healing Our
Heroes Foundation dba The Mission After, Del Mar, CA; Hybrid Plastics,
Inc., Hattiesburg, MS; Iacta Pharmaceuticals, Inc., Irvine, CA;
Intelligent Automation, Inc., Rockville, MD; IRegained, Inc., Sudbury,
CAN; KMASS Solutions, El Paso, TX; Kopis Mobile LLC, Flowood, MS; L-3
Applied Technologies, Inc., San Diego, CA; Levi Diagnostics, Inc., Fall
River, MA; LexisNexis Risk Solutions, Inc., Washington, DC; Life365
Inc., Scottsdale, AZ; luxML LLC, San Antonio, TX; MadApparel Ind. dba
Athos, Redwood City, CA; ManTech Advanced Systems International, Inc.,
Herndon, VA; Medical Center of the Americas Foundation, El Paso, TX;
Medical Informatics Corp., Houston, TX; MEDX SpA, Regi[oacute]n
metropolitana, Santiago de Chile, CHL; Moleculin Biotech, Inc.,
Houston, TX; Movement Rx Physical Therapy, P.C., San Diego, CA;
NanoOxygenic LLC, Dallas, TX; NeurAegis, Inc., Southborough, MA;
Neuronasal, Inc., Wexford, PA; Nexsys Electronics Inc. dba Medweb, San
Francisco, CA; Nostromo LLC, Kennebunk, ME; Novel Technologies Holdings
Limited, Manchester, NH; Noveome Biotherapeutics, Inc., Pittsburg, PA;
Obatala Sciences, Inc., New Orleans, LA; Odin Technologies, Charlotte,
NC; OLGS, Inc., Imperial, PA; Oregon Health & Science University,
Portland, OR; Osteal Therapeutics, Inc., San Clemente, CA; Overseas
Strategic Consulting, Ltd, Philadelphia, PA; Oxygenium, Inc., Great
Neck, NY; Panakeia LLC, Newport News, VA; PercuSense, Inc., Valencia,
CA; Platelet BioGenesis, Inc., Cambridge, MA; Presidio Government
Solutions LLC, Reston, VA; Programs Management Analytics &
Technologies, Inc., Norfolk, VA; Q30 Sports Science LLC, Westport, CT;
QuesGen Systems, Burlingame, CA; Renaissance Biotech LLC, Malibu, CA;
Resolys Bio, Inc., Delanson, NY; ServiceNow, Inc., Vienna, VA;
SpherIngenics, Inc., Richmond, VA; StataDX, Inc., Cambridge, MA;
Synthesis Technologies, Inc., Pasadena, CA; Tanner Research, Inc.,
Duarte, CA; TeleCommunication Systems, Inc., Annapolis, MD; Through The
Cords LLC, Salt Lake City, UT; Traumatic Direct Transfusion Devices
LLC, Raleigh, NC; Tunnell Consulting, Inc., Bethesda, MD; University of
Connecticut, Storrs, CT; University of Kansas Medical Center Research
Institute, Inc., Kansas City, KS; ViiNetwork, Inc ViiMed, Washington,
DC; Wearable Artificial Organs, Inc., Beverly Hills, CA; WearOptimo,
Woolloongabba, Queensland, AUS; Western Michigan University Homer
Stryker M.D. School of Medicine, Kalamazoo, MI; XSurgical, Inc.,
Ipswich, MA; Zansors LLC, Arlington, VA; have withdrawn as parties to
this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
Section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to Section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on April 14,
2022. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on May 13, 2022 (87 FR 29382).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-19656 Filed 9-12-22; 8:45 am]
BILLING CODE P
